How would you summarize the status of the current arsenal for AD and, in particular, the degree to which new systemic therapies are addressing the unmet for long-term disease management in the pediatric and adolescent population?

How would you summarize the status of the current arsenal for AD and, in particular, the degree to which new systemic therapies are addressing the unmet for long-term disease management in the pediatric and adolescent population?

CLICK HERE FOR CME CREDIT Back to Symposium

How would you summarize the status of the current arsenal for AD and, in particular, the degree to which new systemic therapies are addressing the unmet for long-term disease management in the pediatric and adolescent population?

Created by

CMEducation Resources iQ&A Case-By-Case Atopic Dermatitis Medical Intelligence Zone

Presenter

Lawrence Eichenfield, MD

Lawrence Eichenfield, MD

Chief of Pediatric and Adolescent Dermatology
Rady Children's Hospital-San Diego
Vice Chair, Department of Dermatology
Professor of Dermatology and Pediatrics
UC San Diego School of Medicine